Comparing MDxHealth (NASDAQ:MDXH) & MSP Recovery (NASDAQ:MSPR)

MSP Recovery (NASDAQ:MSPR) and MDxHealth (NASDAQ:MDXH) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, risk, analyst recommendations, valuation, profitability, earnings and dividends.

Profitability

This table compares MSP Recovery and MDxHealth’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
MSP Recovery	-7,328.48%	-326.80%	-81.27%
MDxHealth	-29.90%	N/A	-22.51%

Risk & Volatility

MSP Recovery has a beta of -2.31, meaning that its stock price is 331% less volatile than the S&P 500. Comparatively, MDxHealth has a beta of 1.43, meaning that its stock price is 43% more volatile than the S&P 500.

Analyst Ratings

This is a breakdown of current ratings for MSP Recovery and MDxHealth, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
MSP Recovery	1	0	0	0	1.00
MDxHealth	1	1	4	0	2.50

MDxHealth has a consensus price target of $4.62, indicating a potential upside of 953.53%. Given MDxHealth’s stronger consensus rating and higher probable upside, analysts clearly believe MDxHealth is more favorable than MSP Recovery.

Earnings and Valuation

This table compares MSP Recovery and MDxHealth”s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
MSP Recovery	$9.81 million	0.02	-$360.50 million	($572.83)	-0.00
MDxHealth	$110.97 million	0.20	-$33.52 million	($0.65)	-0.68

MDxHealth has higher revenue and earnings than MSP Recovery. MDxHealth is trading at a lower price-to-earnings ratio than MSP Recovery, indicating that it is currently the more affordable of the two stocks.

Institutional & Insider Ownership

3.8% of MSP Recovery shares are owned by institutional investors. 50.5% of MSP Recovery shares are owned by insiders. Comparatively, 1.7% of MDxHealth shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Summary

MDxHealth beats MSP Recovery on 11 of the 14 factors compared between the two stocks.

About MSP Recovery

MSP Recovery, Inc. engages in the development of healthcare recoveries and data analytics software. It also focuses on the identification and recoveries of improper payments made by Medicare, Medicaid, and commercial insurance spaces using data and analytics. The company was founded by John H. Ruiz, Frank C. Quesada, and Diana Diaz on July 8, 2014 and is headquartered in Miami, FL.

About MDxHealth

MDxHealth SA, a commercial-stage precision diagnostics company, provides urologic solutions in the United States, Europe, and internationally. Its testing solutions includes Select mdx, a non-invasive urine test for prostate cancer that measures the expression of two mRNA cancer-related biomarkers; Confirm mdx for prostate cancer tissue test that validates epigenetic test that guides the detection of occult prostate cancer on a patient's previously biopsied negative tissue; and Resolved mdx for urinary tract infection that identifies personalized effective antibiotic options against the patient's infection. The company offers genomic prostate score which provides personalized genomic insights to both physicians and patients navigating the complexities of prostate cancer diagnosis and treatment. It sells its products through urology sales force, consisting of direct sales representatives, strategic account managers, and regional sales managers. The company was formerly known as OncoMethylome Sciences SA and changed its name to MDxHealth SA in October 2010. MDxHealth SA was incorporated in 2003 and is headquartered in Herstal, Belgium.